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Transforming Growth Factor-1 (TGF-1)
Contributes to Kidney Disease
Fibrosis in the kidney leads to progressive renal failure.
This fibrosis, as well as nephron degeneration, can result
from high levels of TGF-1 in the kidney tubules. To
clarify the mechanisms regulating TGF-1–mediated re-
nal fibrosis, Koesters et al (Am J Pathol 2010, 177:632–
643) overexpressed TGF-1 in renal tubules of mice.
Nephron degeneration in this system was mediated by
tubular dedifferentiation and autophagic decomposition
of the tubular cells, resulting in atubular glomeruli. How-
ever, there was no evidence of epithelial to mesenchymal
transition (transition of tubular epithelial cells to fibro-
blasts and myofibroblasts), a process that is thought to
be prominent in fibrosis. Taken together, these data sug-
gest that TGF-1 may play a novel role in autophagy of
renal cells, thus contributing to renal fibrosis.
T-Cell Lymphoma Microenvironment
Peripheral T-cell lymphomas (PTCLs) are rare but have
poor prognosis. Subtype differentiation of peripheral T-
cell lymphomas, such as autoimmunoblastic T-cell lym-
phoma (AITL) and peripheral T-cell lymphomas not oth-
erwise specified (PTCL/NOS), is critical for the
application of specific therapeutic strategies. Tripodo et
al (Am J Pathol 2010, 177:792–802) therefore examined
the immunological microenvironment of PTCLs to find
diagnostic criteria to differentiate AITLs and PTCL/NOS.
They found that T helper 17 (Th17) cells and mast cells
directly contributed to the proinflammatory microenviron-
ment of AITLs but not PTCL/NOS. From their data, they
propose that AITL cells may directly recruit mast cells,
which then secrete factors that result in the proinflamma-
tory, Th17-generating microenvironment that leads to au-
toimmunity in these patients.
Novel Cause for Genetic Tooth Decay
Rickets is associated with severe bone deformities, in-
cluding dental ailments due to impaired dentin mineral-
ization. Familial hypophosphatemic rickets is often
caused by a mutation in the endopeptidase PHEX (phos-
phate regulating gene with homologies to endopepti-
dases on the X chromosome). Boukpessi et al (Am J
Pathol 2010, 177:803–812) hypothesized that PHEX im-
pairment resulted in the release of the C-terminal ASARM
(acidic serine and aspartate rich motif) peptide, which is
known to inhibit dentin mineralization. They observed
abnormal cleavage of MEPE (matrix extracellular phos-
phoglycoprotein), the parent protein of ASARM, in hy-
pophosphatemic patients. These effects were attenuated
by a diet of 1-hydroxylated-vitamin D and phosphate
during growth. The presence of the ASARM peptide may
thus contribute to impaired dentin mineralization in rick-
ets, in a manner compensated for by vitamin D and
phosphate.
Preventing HIV-Associated Nephropathy
HIV-associated nephropathy is characterized by cell pro-
liferation in both glomerular and tubular lesions. To de-
termine whether mammalian target of rapamycin (mTOR),
which plays a key role in cell growth, was involved in this
proliferative phenotype, Kumar et al (Am J Pathol 2010,
177:813–821) examined mTOR activation in a mouse
model of HIV-associated nephropathy. Both mTOR and
its downstream targets were phosphorylated at higher
levels in these mice as compared with controls, indicat-
ing enhanced activation of the mTOR signaling pathway.
In addition, both mTOR activation and renal disease
could be attenuated by treatment with rapamycin, which
inhibits the mTOR pathway. This report therefore sup-
ports mTOR as a therapeutic target for HIV-associated
nephropathy.
Morphine Inhibits Tumor Angiogenesis
Morphine is commonly used to treat cancer pain, but the
effects of morphine use on tumor growth remain contro-
versial. Using a clinically relevant morphine dose in a
mouse model of Lewis lung carcinoma, Koodie et al
(Am J Pathol 2010, 177:984–997) examined the effect of
morphine use on tumor angiogenesis. They found that
chronic morphine use decreased levels of tumor angio-
genesis in a manner dependent on the opioid receptor.
This effect was mediated by suppression of hypoxia-
induced signaling, leading to a reduction in the levels of
proangiogenic factors. Therefore, morphine may not only
serve as an analgesic for cancer patients but may also
inhibit tumor angiogenesis and growth.
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